 |
Previous Article | Next Article 
The Journal of Neuroscience, April 1, 2001, 21(7):2536-2545
Contribution of Endogenous Enkephalins to the Enhanced Analgesic
Effects of Supraspinal µ Opioid Receptor Agonists after Inflammatory
Injury
Robert W.
Hurley and
Donna L.
Hammond
Department of Anesthesia and Critical Care and The Committee on
Neurobiology, University of Chicago, Chicago, Illinois 60637
This study examined a mechanism responsible for the enhanced
antihyperalgesic and antinociceptive effects of the µ opioid receptor
agonist (ORA) [D-Ala2,
NMePhe4, Gly5-ol]enkephalin
(DAMGO) microinjected in the rostroventromedial medulla (RVM) of rats
with inflammatory injury induced by injection of complete Freund's
adjuvant (CFA) in one hindpaw. In rats injected with CFA 4 hr earlier,
microinjection of the µ opioid receptor antagonist
D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2
(CTAP) in the RVM antagonized both the marginal enhancement of the
potency of DAMGO and its antinociceptive effect. The opioid
receptor antagonist naltriben (NTB) was without effect. In rats
injected with CFA 2 weeks earlier, CTAP antagonized the effects of
DAMGO to a lesser extent. However, NTB completely prevented the
enhancement of the potency of DAMGO, whereas it did not antagonize
DAMGO's antinociceptive effects. Microinjection of NTB alone, but not
CTAP in the RVM of CFA-treated rats, enhanced the hyperalgesia present
in the ipsilateral hindpaw and induced hyperalgesia in the
contralateral, uninjured hindpaw. These results suggest that persistent
inflammatory injury increased the release in the RVM of opioid peptides
with preferential affinity for the opioid receptor, which can
interact in a synergistic or additive manner with an exogenously
administered µ opioid receptor agonist. Indeed, the levels of
[Met5]enkephalin and
[Leu5]enkephalin were increased in the RVM and in
other brainstem nuclei in CFA-treated rats. This increase most likely
presents a compensatory neuronal response of the CNS of the injured
animal to mitigate the full expression of inflammatory pain and to
enhance the antinociceptive and antihyperalgesic effects of exogenously
administered µ opioid receptor analgesics.
Key words:
µ opioid receptor; opioid receptor; antinociception; complete Freund's adjuvant; hyperalgesia; nucleus
raphe magnus
Copyright © 2001 Society for Neuroscience 0270-6474/01/2172536-10$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
L. Zhang and D. L. Hammond
Substance P Enhances Excitatory Synaptic Transmission on Spinally Projecting Neurons in the Rostral Ventromedial Medulla After Inflammatory Injury
J Neurophysiol,
August 1, 2009;
102(2):
1139 - 1151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Hathway, S. Koch, L. Low, and M. Fitzgerald
The changing balance of brainstem\#8211;spinal cord modulation of pain processing over the first weeks of rat postnatal life
J. Physiol.,
June 15, 2009;
587(12):
2927 - 2935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Hellman, T. S. Brink, and P. Mason
Activity of Murine Raphe Magnus Cells Predicts Tachypnea and On-Going Nociceptive Responsiveness
J Neurophysiol,
December 1, 2007;
98(6):
3121 - 3133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Sykes, S. R. White, R. W. Hurley, H. Mizoguchi, L. F. Tseng, and D. L. Hammond
Mechanisms Responsible for the Enhanced Antinociceptive Effects of {micro}-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain
J. Pharmacol. Exp. Ther.,
August 1, 2007;
322(2):
813 - 821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, R. J. Traub, and A. Z. Murphy
Persistent pain model reveals sex difference in morphine potency
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2006;
291(2):
R300 - R306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Guan, J. Borzan, R. A. Meyer, and S. N. Raja
Windup in dorsal horn neurons is modulated by endogenous spinal mu-opioid mechanisms.
J. Neurosci.,
April 19, 2006;
26(16):
4298 - 4307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Kincaid, M. J. Neubert, M. Xu, C. J. Kim, and M. M. Heinricher
Role for Medullary Pain Facilitating Neurons in Secondary Thermal Hyperalgesia
J Neurophysiol,
January 1, 2006;
95(1):
33 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. Sterious and E. A. Walker
Potency Differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an Antagonist of Peptide and Alkaloid {micro}-Agonists in an Antinociception Assay
J. Pharmacol. Exp. Ther.,
January 1, 2003;
304(1):
301 - 309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Miki, Q.-Q. Zhou, W. Guo, Y. Guan, R. Terayama, R. Dubner, and K. Ren
Changes in Gene Expression and Neuronal Phenotype in Brain Stem Pain Modulatory Circuitry After Inflammation
J Neurophysiol,
February 1, 2002;
87(2):
750 - 760.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|